Expression of maspin and glutathionine-S-transferase-π in normal human prostate and prostatic carcinomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 5, 2010, Pages 429-432

  Lovrić, Eva ^a   Gatalica, Zoran ^c   Eyzaguirre, Eduardo ^d   Krušlin, Božo ^b  

^a akovec County Hospital   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

glutathionine S transferase p; Maspin; prostate cancer

Indexed keywords

GLUTATHIONE TRANSFERASE P1; MASPIN;

ARTICLE; BASAL CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; ENZYME REGULATION; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTEIN EXPRESSION; STROMA CELL; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; BIOPSY; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; GLUTATHIONE S-TRANSFERASE PI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; SERPINS;

EID: 77957592757     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181dbc77e     Document Type: Article

References (22)

1. Suzuki H, Toyota M, Kondo Y., et al. Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome. Methods Mol Biol. 2009; 512: 55-69.
2. Federico A, Morgillo F, Tuccillo C., et al. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007; 121: 2381-2386.
3. Yegnasubramanian S, Haffner MC, Zhang Y, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 2008; 68: 8954-8967.
4. Yegnasubramanian S, Kowalski J, Gonzalgo M.L., et al. Hyper-methylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004; 64: 1975-1986.
5. Khalkhali-Ellis Z. Maspin: the new frontier. Clin Cancer Res. 2006; 12: 7279-7283.
6. Lee WH, Morton RA, Epstein J.I., et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A. 1994; 91: 11733-11737.
7. Okino ST, Pookot D, Majid S., et al. Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol carcinog. 2007; 46: 839-846.
8. Nakayama M, Bennett CJ, Hicks J.L., et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol. 2003; 163: 923-933.
9. Brooks JD, Weinstein M, Lin X., et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1988; 7: 531-536.
10. Yin S, Li X, Meng Y., et al. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J Biol Chem. 2005; 280: 34985-34996.
11. Li X, Yin S, Meng Y., et al. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Research. 2006; 66: 9323-9329.
12. Nelson WG, De Marzo AM, Yegnasubramanian S. Epigenetic alterations in human prostate cancers. Endocrinology. 2009; 150: 3991-4002.
13. Latha K, Zhang W, Cella N., et al. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol. 2005; 25: 1737-1748.
14. Teoh SS, Whisstock JC, Bird PI Maspin (serpinb5) is an obligate intracellular serpin. J Biol Chem. 2010; 285: 10862-10869.
15. Pierson CR, McGowen R, Grignon D., et al. Maspin is up-regulated in premalignant prostate epithelia. Prostate. 2002; 53: 255-262.
16. Lockett J, Yin S, Li X., et al. Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem. 2006; 97: 651-660.
17. Cher ML, Biliran HR Jr, Bhagat S, et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci. 2003; 100: 7847-7852.
18. Zhang M, Volpert O, Shi Y.H., et al. Maspin is an angiogenesis inhibitor. Nat Med. 2000; 6: 196-199.
19. Hall DC, Johnson-Pais TL, Grubbs B., et al. Maspin reduces prostate cancer metastasis to bone. Urol Oncol. 2008; 26: 652-658.
20. Bostwick DG, Meiers I, Shanks JH Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adeno-carcinoma. Human pathol. 2007; 38: 1394-1401.
21. Agalliu I, Lin DW, Salinas C.A., et al. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate. 2006; 66: 1535-1541.
22. McIlwain CC, Townsend DM, Tew KD Glutathioone-S-trasferase polymorphsims: cancer incidence and therapy. Oncogene. 2006; 25: 1639-1648.